Developer docs
API playgroundTry for free, no card

Search company profiles

S3 Ventures

Full company profile

uuid000035a

Namestring
S3 Ventures
Legal namestring
S3 Ventures
Websiteurl
s3vc.com
Company typeenum
Private
Founded yearint
2005
Descriptiontext

S3 Ventures is a venture capital firm headquartered in Austin, Texas, founded in 2005 by Brian Smith. The firm is backed by a single philanthropic limited partner, a structure the firm explicitly cites as enabling patient capital without the fundraising and LP-pressure constraints typical of multi-LP funds. S3 Ventures leads Seed, Series A, and Series B rounds with initial checks of $500,000 to $15 million-plus and reserves the right to invest $25 million-plus over time, operating a single primary office in Austin with a stated geographic reach across 13 U.S. states.

The firm concentrates its portfolio across two verticals: Business Technology (software applications, IT infrastructure, developer tools and platforms, hardware) and Healthcare Technology (medical devices and software across diagnosis, treatment, and wellness). Beyond capital, S3 Ventures supplements portfolio companies with operational resources, including the "Startup Toolbox" of templates and calculators (SaaS Operating Model, Term Loan Calculator, Stagger Charts, Cap Table Template, Unit Economics Workbook) and a founder-facing newsletter. The firm does not operate technology products of its own; its "platform" is the investment and value-add program surrounding its portfolio.

S3 Ventures manages over $1 billion in assets across eight funds, with Fund VIII at $250 million announced in December 2025 coinciding with the firm's 20th anniversary. The firm reports 75-plus startup investments to date, 40-plus currently active portfolio companies, and 35-plus exits collectively valued at over $3 billion. Notable exits include Acessa Health (acquired by Hologic), Briggo (Coca-Cola), Complex (Verizon and Hearst), Favor (HEB), Levelset (Procore), and Gravitant (IBM). The team of 11-50 employees is led by founder and Managing Director Brian Smith alongside Principal Joe Curry and associates.

Short descriptiontext

S3 Ventures is an Austin, Texas-based venture capital firm founded in 2005 that invests Seed through Series B in U.S. business technology and healthcare technology startups, managing over $1B in AUM across eight funds with a single philanthropic limited partner.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAustin, United States
HQ citystring
Austin
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture capital, seed stage investing, series A funding, healthcare technology, business technology
Industry2 codes
PRIMARYFSANAAAB
Early-Stage Venture Capital (Series A/B)
SECONDARYFSANAAAD
Sector-Focused Venture Capital (Vertical Specialists)
Product category
Venture Capital
Social media profiles2 records
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

S3 Ventures is a venture capital firm that invests patient equity capital in early- to growth-stage technology and healthcare companies, leading Seed, Series A, and Series B rounds with check sizes of $500K to $15M+ initially and $25M+ over time. The firm provides portfolio companies with operational resources, mentorship, and network access, organized around two verticals: Business Technology and Healthcare Technology.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Portfolio companies have raised over $3.5B in total
+1 more record
Product overview1 text field

S3 Ventures is a venture capital firm headquartered in Austin, Texas, that provides patient capital and strategic resources to early-stage software and healthcare technology companies. Founded in 2005 and backed by a single limited partner, the firm leads Seed, Series A, and Series B rounds with initial investments of $500,000 to $15 million+, with the ability to invest $25 million+ over time. S3 Ventures manages over $1 billion in assets across more than 75 startup investments, with 40+ active portfolio companies and 35+ exits. The firm's investment strategy spans two primary verticals: Business Technology (software applications, IT infrastructure, developer tools, platforms, hardware) and Healthcare Technology (medical devices and software for diagnosis, treatment, and wellness). The firm offers portfolio companies access to a Startup Toolbox containing operational templates, calculators, and frameworks including SaaS Operating Model, Term Loan Calculator, Stagger Charts, Cash Management best practices, Sales Quota Workbook, Sales Forecast Workbook, Cap Table template, Option Grants Workbook, Unit Economics Workbook, and a Starter Kit for Texas Founders.

Product and service5 records
1S3 Ventures Seed Funding
CategoryVenture Capital - Seed Stage
Description

Early-stage equity investment in startup companies, typically the first institutional round of funding, designed to help entrepreneurs build initial product and market traction. S3 Ventures leads Seed rounds with initial investments within its $500K to $15M+ range, targeting Business Technology and Healthcare Technology startups across the U.S.

2S3 Ventures Series A Funding
CategoryVenture Capital - Series A
Description

Growth-stage equity investment for startups that have achieved product-market fit and seek capital to scale operations and revenue. S3 Ventures leads Series A rounds with initial investments up to $15M+, supporting Business Technology and Healthcare Technology companies across the U.S.

3S3 Ventures Series B Funding
CategoryVenture Capital - Series B
Description

Later-stage growth equity investment for scaling startups, providing larger capital injections to accelerate market expansion, team building, and revenue growth. S3 Ventures leads Series B rounds with initial investments up to $15M+ and the ability to invest $25M+ over time across its portfolio companies.

4S3 Ventures Fund VIII
CategoryVenture Capital Fund
Description

The eighth vintage of S3 Ventures' flagship venture capital fund, capitalized at $250 million and backed by a single philanthropic limited partner. Fund VIII will deploy patient capital into software and healthcare technology startups across the U.S.

5S3 Ventures Startup Toolbox
CategoryInvestor Resources / Founder Tools
Description

A free resource library offered by S3 Ventures to founders and entrepreneurs, containing operational templates, calculators, and frameworks including the SaaS Operating Model, Term Loan Calculator, Stagger Charts, Cash Management best practices, Sales Quota Workbook, Sales Forecast Workbook, Cap Table template, Option Grants Workbook, Unit Economics Workbook, and a Starter Kit for Texas Founders.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Boulder-based early-stage VC investing in B2B software and healthcare with comparable fund size and Seed-to-Series B stage focus. Highly comparable strategy and check-size philosophy.

TypeBroad incumbent
Description

Large multi-stage VC with healthcare and B2B technology focus that co-leads rounds S3 participates in (e.g., Endovascular Engineering). A scaled incumbent operating in the same categories.

TypeDirect peer
Description

Austin-based early-stage VC focused on Texas-based technology startups with similar check sizes and Seed/Series A leadership approach. Highly comparable as a same-geography, same-stage Texas tech investor.

TypeDirect peer
Description

Austin-based venture firm investing in Seed and Series A rounds across Texas and the broader US, with comparable fund size and stage focus. Frequently co-invests with S3 Ventures (e.g., BrainCheck, LeanDNA).

TypeDirect peer
Description

Houston-based early-stage VC investing in B2B software and healthcare-adjacent startups across Texas. Same regional orientation and stage focus as S3 Ventures.

TypeRegional player
Description

Austin-focused pre-seed and seed fund backing local Texas founders. Operates in an adjacent stage to S3's Seed and Series A activity and shares its Austin deal-flow ecosystem.

TypeDirect peer
Description

Austin-based growth-stage VC focused on B2B software companies, with similar check sizes and Texas roots. Overlaps with S3 Ventures on later-stage business-technology opportunities.

TypeDirect peer
Description

Austin-based healthcare-focused VC investing in medical devices and digital health. Highly comparable healthcare vertical focus; co-invested with S3 in Endovascular Engineering.

TypeRegional player
Description

Texas-centered accelerator and seed investor operating in the same Austin startup ecosystem, often funneling Seed-stage companies toward S3 for Series A follow-on.

TypeBroad incumbent
Description

European-anchored healthcare VC active in US medical device markets; co-led Endovascular Engineering Series C with S3 Ventures. A larger, sector-specialized comparable on the healthcare vertical.

Market position
Strengths1 record

Each record includes

Headline, Details, Source

Weaknesses1 record

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment143 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

S3 Ventures

Venture Capitals3vc.com

S3 Ventures is an Austin, Texas-based venture capital firm founded in 2005 that invests Seed through Series B in U.S. business technology and healthcare technology startups, managing over $1B in AUM across eight funds with a single philanthropic limited partner.

What S3 Ventures does

S3 Ventures is a venture capital firm headquartered in Austin, Texas, founded in 2005 by Brian Smith. The firm is backed by a single philanthropic limited partner, a structure the firm explicitly cites as enabling patient capital without the fundraising and LP-pressure constraints typical of multi-LP funds. S3 Ventures leads Seed, Series A, and Series B rounds with initial checks of $500,000 to $15 million-plus and reserves the right to invest $25 million-plus over time, operating a single primary office in Austin with a stated geographic reach across 13 U.S. states.

The firm concentrates its portfolio across two verticals: Business Technology (software applications, IT infrastructure, developer tools and platforms, hardware) and Healthcare Technology (medical devices and software across diagnosis, treatment, and wellness). Beyond capital, S3 Ventures supplements portfolio companies with operational resources, including the "Startup Toolbox" of templates and calculators (SaaS Operating Model, Term Loan Calculator, Stagger Charts, Cap Table Template, Unit Economics Workbook) and a founder-facing newsletter. The firm does not operate technology products of its own; its "platform" is the investment and value-add program surrounding its portfolio.

S3 Ventures manages over $1 billion in assets across eight funds, with Fund VIII at $250 million announced in December 2025 coinciding with the firm's 20th anniversary. The firm reports 75-plus startup investments to date, 40-plus currently active portfolio companies, and 35-plus exits collectively valued at over $3 billion. Notable exits include Acessa Health (acquired by Hologic), Briggo (Coca-Cola), Complex (Verizon and Hearst), Favor (HEB), Levelset (Procore), and Gravitant (IBM). The team of 11-50 employees is led by founder and Managing Director Brian Smith alongside Principal Joe Curry and associates.

S3 Ventures firmographics

Firmographics
Name
S3 Ventures
Legal name
S3 Ventures
Website
https://s3vc.com
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
11–50 employees
Short description
S3 Ventures is an Austin, Texas-based venture capital firm founded in 2005 that invests Seed through Series B in U.S. business technology and healthcare technology startups, managing over $1B in AUM across eight funds with a single philanthropic limited partner.
Ownership category
akta.pro rank

S3 Ventures industry classification

Industry
Product category
Venture Capital
akta.pro industry
PRIMARYFSANAAAB
Early-Stage Venture Capital (Series A/B)
SECONDARYFSANAAAD
Sector-Focused Venture Capital (Vertical Specialists)

Keywords

  • Venture capital
  • Seed stage investing
  • Series A funding
  • Healthcare technology
  • Business technology

Where S3 Ventures is headquartered

Location

Headquarters

HQ city
Austin
HQ country
United States
HQ region
North America

Offices1 record

Markets served

S3 Ventures business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Infrastructure

Distribution channels1 record

Marketing channels4 records

S3 Ventures product offering

Product offering

Core offering

S3 Ventures is a venture capital firm that invests patient equity capital in early- to growth-stage technology and healthcare companies, leading Seed, Series A, and Series B rounds with check sizes of $500K to $15M+ initially and $25M+ over time. The firm provides portfolio companies with operational resources, mentorship, and network access, organized around two verticals: Business Technology and Healthcare Technology.

Product overview

S3 Ventures is a venture capital firm headquartered in Austin, Texas, that provides patient capital and strategic resources to early-stage software and healthcare technology companies. Founded in 2005 and backed by a single limited partner, the firm leads Seed, Series A, and Series B rounds with initial investments of $500,000 to $15 million+, with the ability to invest $25 million+ over time. S3 Ventures manages over $1 billion in assets across more than 75 startup investments, with 40+ active portfolio companies and 35+ exits. The firm's investment strategy spans two primary verticals: Business Technology (software applications, IT infrastructure, developer tools, platforms, hardware) and Healthcare Technology (medical devices and software for diagnosis, treatment, and wellness). The firm offers portfolio companies access to a Startup Toolbox containing operational templates, calculators, and frameworks including SaaS Operating Model, Term Loan Calculator, Stagger Charts, Cash Management best practices, Sales Quota Workbook, Sales Forecast Workbook, Cap Table template, Option Grants Workbook, Unit Economics Workbook, and a Starter Kit for Texas Founders.

Differentiator

Problem solved

Functional benefit

Products and services

  • S3 Ventures Seed Funding Early-stage equity investment in startup companies, typically the first institutional round of funding, designed to help entrepreneurs build initial product and market traction. S3 Ventures leads Seed rounds with initial investments within its $500K to $15M+ range, targeting Business Technology and Healthcare Technology startups across the U.S.
  • S3 Ventures Series A Funding Growth-stage equity investment for startups that have achieved product-market fit and seek capital to scale operations and revenue. S3 Ventures leads Series A rounds with initial investments up to $15M+, supporting Business Technology and Healthcare Technology companies across the U.S.
  • S3 Ventures Series B Funding Later-stage growth equity investment for scaling startups, providing larger capital injections to accelerate market expansion, team building, and revenue growth. S3 Ventures leads Series B rounds with initial investments up to $15M+ and the ability to invest $25M+ over time across its portfolio companies.
  • S3 Ventures Fund VIII The eighth vintage of S3 Ventures' flagship venture capital fund, capitalized at $250 million and backed by a single philanthropic limited partner. Fund VIII will deploy patient capital into software and healthcare technology startups across the U.S.
  • S3 Ventures Startup Toolbox A free resource library offered by S3 Ventures to founders and entrepreneurs, containing operational templates, calculators, and frameworks including the SaaS Operating Model, Term Loan Calculator, Stagger Charts, Cash Management best practices, Sales Quota Workbook, Sales Forecast Workbook, Cap Table template, Option Grants Workbook, Unit Economics Workbook, and a Starter Kit for Texas Founders.

Quantifiable outcome

  • Portfolio companies have raised over $3.5B in total
  • +1 more outcomes

Companies that use S3 Ventures

Customer profile

Segments2 records

Ideal customer profiles2 records

S3 Ventures technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

S3 Ventures partnerships and signals

Strategic signal

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

S3 Ventures competitors and assessment

Company assessment

Direct peers

  • Foundry Group: Boulder-based early-stage VC investing in B2B software and healthcare with comparable fund size and Seed-to-Series B stage focus. Highly comparable strategy and check-size philosophy.
  • LiveOak Venture Partners: Austin-based early-stage VC focused on Texas-based technology startups with similar check sizes and Seed/Series A leadership approach. Highly comparable as a same-geography, same-stage Texas tech investor.
  • Next Coast Ventures: Austin-based venture firm investing in Seed and Series A rounds across Texas and the broader US, with comparable fund size and stage focus. Frequently co-invests with S3 Ventures (e.g., BrainCheck, LeanDNA).
  • Mercury Fund: Houston-based early-stage VC investing in B2B software and healthcare-adjacent startups across Texas. Same regional orientation and stage focus as S3 Ventures.
  • Elsewhere Partners: Austin-based growth-stage VC focused on B2B software companies, with similar check sizes and Texas roots. Overlaps with S3 Ventures on later-stage business-technology opportunities.
  • Santé Ventures: Austin-based healthcare-focused VC investing in medical devices and digital health. Highly comparable healthcare vertical focus; co-invested with S3 in Endovascular Engineering.

Broad incumbents

  • Norwest Venture Partners: Large multi-stage VC with healthcare and B2B technology focus that co-leads rounds S3 participates in (e.g., Endovascular Engineering). A scaled incumbent operating in the same categories.
  • Gilde Healthcare: European-anchored healthcare VC active in US medical device markets; co-led Endovascular Engineering Series C with S3 Ventures. A larger, sector-specialized comparable on the healthcare vertical.

Regional players

  • ATX Seed Ventures: Austin-focused pre-seed and seed fund backing local Texas founders. Operates in an adjacent stage to S3's Seed and Series A activity and shares its Austin deal-flow ecosystem.
  • Capital Factory: Texas-centered accelerator and seed investor operating in the same Austin startup ecosystem, often funneling Seed-stage companies toward S3 for Series A follow-on.

Market position

Strengths1 record

Weaknesses1 record

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

S3 Ventures social profiles

Digital presence

S3 Ventures financial estimates

Financial estimate

Revenue estimate

Valuation estimate

S3 Ventures leadership team

Management profile

Number of profiles

Profiles4 records

S3 Ventures funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

S3 Ventures M&A and investment

M&A and investment

M&A

Investments143 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about S3 Ventures

What does S3 Ventures do?

S3 Ventures is a venture capital firm that invests patient equity capital in early- to growth-stage technology and healthcare companies, leading Seed, Series A, and Series B rounds with check sizes of $500K to $15M+ initially and $25M+ over time. The firm provides portfolio companies with operational resources, mentorship, and network access, organized around two verticals: Business Technology and Healthcare Technology.

Is S3 Ventures a public or private company?

S3 Ventures is a private company. It is classified as venture growth investor backed and is currently operating.

When was S3 Ventures founded?

S3 Ventures was founded in 2005. It employs 11 to 50 people.

Where is S3 Ventures based?

S3 Ventures is headquartered in Austin, United States, in the North America region.

Who are S3 Ventures's main competitors?

Direct peers on record are Foundry Group, LiveOak Venture Partners, Next Coast Ventures, Mercury Fund, Elsewhere Partners and Santé Ventures. Broad incumbents are Norwest Venture Partners and Gilde Healthcare. Regional players are ATX Seed Ventures and Capital Factory.

Does S3 Ventures have an API?

No public API is recorded for S3 Ventures.

What industry is S3 Ventures in?

S3 Ventures's product category is Venture Capital. Its primary akta.pro industry code is FSANAAAB, Early-Stage Venture Capital (Series A/B), with a secondary code of FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists).

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FinSMEsMedical Microinstruments Raises $125M in Series D FundingMedical Microinstruments raised $125M in Series D financing led by BioStar Capital, with participation from S3 Ventures, Angelini Ventures, and an undisclosed strategic investor. The funds will expand business reach and advance clinical evidence for its Symani robotic microsurgery system, which has about 50 installed systems and 3,500 procedures worldwide.Mpo-magRapidPulse Pockets $48 Million for Stroke Aspiration Tech DevelopmentRapidPulse closed a $48 million Series B round co-led by Medtronic, TechWald, and S3 Ventures. The financing will complete its TURBO study and expand clinical experience, with potential FDA approval if data permits.Pulse 2.0Cloverleaf AI Raises $8 Million Series A Led By S3 VenturesCloverleaf AI raised $8 million in a Series A led by S3 Ventures, with participation from Jackson Square Ventures, Ivy Ventures, and Tawani Ventures. The Denver-based company provides a B2G sales intelligence platform monitoring over 70,000 agencies and 200,000 speakers, with customers like Uber Transit generating up to $1 million in pipeline per representative per quarter.SalesTech StarCloverleaf AI Raises $8 Million Series A to Bring Pre-RFP Intelligence to B2G Sales Teams Nationwide.Cloverleaf AI raised $8 million in a Series A led by S3 Ventures in January. The B2G sales intelligence platform tracks 70,000+ agencies and 200k+ speakers, with customers like Uber Transit seeing up to $1 million in pipeline per rep per quarter.FinSMEsCloverleaf AI Raises $8M in Series A FundingCloverleaf AI, a Denver-based B2G sales intelligence platform, raised $8M in Series A funding led by S3 Ventures. The company will use the funds to expand hiring, scale platform capabilities, and broaden its public-sector dataset. The platform monitors 70,000+ agencies and 200k+ speakers.Venture Capital Access OnlineCloverleaf AI Raises $8 Million Series A to Bring Pre-RFP Intelligence to B2G Sales Teams Nationwide.Cloverleaf AI closed an $8 million Series A in January, led by S3 Ventures, to fund its B2G sales intelligence platform. The platform monitors 70,000+ public-sector agencies and 200,000+ speakers, with customers like Uber Transit seeing up to $1 million in pipeline per rep per quarter.Venture Capital Access OnlineMaxQ Medical Raises $31.5 Million Series A, Backed by Olympus, to Advance its Prostate Care PlatformMaxQ Medical closed a $31.5 million Series A led by Atlantic Blue Ventures, S3 Ventures, and Olympus Innovation Ventures. The funds will support its transurethral imaging and therapy system for BPH and prostate cancer, with plans to expand into focal therapy and diagnostics.MorningstarMaxQ Medical Raises $31.5 Million Series A, Backed by Olympus, to Advance its Prostate Care PlatformMaxQ Medical closed a $31.5 million Series A financing led by Atlantic Blue Ventures, S3 Ventures, and Olympus Innovation Ventures. The funds will support its transurethral imaging and therapy system for prostate care, with the first indication for benign prostate hyperplasia and plans to expand into prostate cancer focal therapy and diagnostics.S3VcFunding Announcement — S3 Ventures: Born in Texas, Investing NationwideMaxQ Medical closed a $31.5 million Series A financing led by Atlantic Blue Ventures, S3 Ventures, and Olympus Innovation Ventures. The funds will support its transurethral imaging and therapy system for BPH and prostate cancer, with clinical evaluations underway. The company plans to expand into focal therapy and broader diagnostics.FinSMEsMaxQ Medical Raises $31.5M in Series A FundingMaxQ Medical raised $31.5M in Series A financing led by Atlantic Blue Ventures, S3 Ventures, and Olympus Innovation Ventures. The company will use the funds to grow its team and advance its clinical program for prostate care. It plans to expand beyond benign prostate hyperplasia into focal therapy for prostate cancer.